Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             507 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions Klasen, Benedikt

72-73 C p. 80-93
artikel
2 A brief history of the Society of Radiopharmaceutical Sciences Coenen, Heinz H.

72-73 C p. 31-34
artikel
3 Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology Fassbender, Thomas F.
2019
72-73 C p. 32-38
artikel
4 A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models Ferguson, Simon

72-73 C p. 74-83
artikel
5 A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models Zhang-Yin, Jules

72-73 C p. 88-95
artikel
6 A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts Cho, Hyungjun

72-73 C p. 11-19
artikel
7 A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3 Man, Francis

72-73 C p. 31-40
artikel
8 Alanine and glycine conjugates of (2S,4R)-4-[18F]fluoroglutamine for tumor imaging Zha, Zhihao
2018
72-73 C p. 19-28
artikel
9 Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation Alonso Martinez, Luis Michel
2018
72-73 C p. 36-42
artikel
10 Alkaline degradation of lyophilized DMSA prior to labeling with 99mTc: Identification and development of the degradation pathway by HPLC and MS Almeida, Erika V.
2018
72-73 C p. 20-27
artikel
11 Alpha emitting nuclides for targeted therapy Hatcher-Lamarre, Jasmine L.

72-73 C p. 228-240
artikel
12 Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors Maina, Theodosia
2017
72-73 C p. 57-62
6 p.
artikel
13 A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor Petrulli, J. Ryan
2017
72-73 C p. 56-61
artikel
14 An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT) Baimukhanova, Ayagoz

72-73 C p. 35-43
artikel
15 An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation Chakravarty, Rubel
2018
72-73 C p. 8-19
artikel
16 A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter Vraka, Chrysoula
2018
72-73 C p. 29-36
artikel
17 An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges Bogni, A.
2019
72-73 C p. 11-19
artikel
18 An original radio-biomimetic approach to synthesize radiometabolites for PET imaging Auvity, Sylvain

72-73 C p. 10-14
artikel
19 A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation Tekin, Volkan

72-73 C p. 20-31
artikel
20 Applying radiobiology to clinical molecular radiotherapy Murray, Iain

72-73 C p. 1-3
artikel
21 Approaches to improve metabolic stability of a statine-based GRP receptor antagonist Popp, Ilinca
2017
72-73 C p. 22-29
8 p.
artikel
22 A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator Jang, Jaewoong

72-73 C p. 1-9
artikel
23 A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo Tang, Yu
2019
72-73 C p. 23-31
artikel
24 A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals Sharma, Sai Kiran
2019
72-73 C p. 32-38
artikel
25 A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept Chen, Wen

72-73 C p. 107-114
artikel
26 A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications Mastren, Tara

72-73 C p. 69-73
artikel
27 Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe Mizuno, Yuki

72-73 C p. 30-36
artikel
28 A simple device to convert a small-animal PET scanner into a multi-sample tissue and injection syringe counter Green, Michael V.
2017
72-73 C p. 9-13
5 p.
artikel
29 A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain Kilbourn, Michael R.
2017
72-73 C p. 34-37
artikel
30 Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging Singh, Nisha
2018
72-73 C p. 32-39
artikel
31 Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid Kobayashi, Masato

72-73 C p. 92-97
artikel
32 Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3+ Kelly, James M.
2017
72-73 C p. 38-46
artikel
33 Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer Michalski, Kerstin

72-73 C p. 37-43
artikel
34 Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation Choi, Jaeyeon
2018
72-73 C p. 10-20
artikel
35 211At labeled substance P (5–11) as potential radiopharmaceutical for glioma treatment Lyczko, Monika
2017
72-73 C p. 1-8
8 p.
artikel
36 A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability Feng, Yutian
2018
72-73 C p. 1-10
artikel
37 Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy Madsen, Karina Lindbøg

72-73 C p. 35-40
artikel
38 Auger: The future of precision medicine Pirovano, Giacomo

72-73 C p. 50-53
artikel
39 A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus Kawamura, Kazunori
2017
72-73 C p. 1-7
7 p.
artikel
40 Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors Lindner, Simon

72-73 C p. 86-95
artikel
41 Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors Huang, Shun

72-73 C p. 64-71
artikel
42 Automated radiosynthesis of 5-[11C]l-glutamine, an important tracer for glutamine utilization Rosenberg, Adam J.
2018
72-73 C p. 10-14
artikel
43 Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans Caillé, Fabien

72-73 C p. 20-27
artikel
44 Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images Cysouw, Matthijs C.F.
2017
72-73 C p. 18-24
7 p.
artikel
45 B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models Kasten, Benjamin B.
2017
72-73 C p. 23-30
artikel
46 Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers Yang, Qiao

72-73 C p. 32-37
artikel
47 Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies Doot, Robert K.

72-73 C p. 1-8
artikel
48 Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(l-lactic acid) microspheres Bakker, Robbert C.
2019
72-73 C p. 11-18
artikel
49 BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain van der Wildt, Berend

72-73 C p. 44-51
artikel
50 Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents Ogata, Aya

72-73 C p. 52-58
artikel
51 Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety Hu, Kun
2017
72-73 C p. 43-50
8 p.
artikel
52 Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d 2: A comparison with [18F]FDG Oh, Chiwoo

72-73 C p. 98-103
artikel
53 Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors Vaidyanathan, Ganesan

72-73 C p. 18-30
artikel
54 Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam Mastren, Tara
2017
72-73 C p. 24-29
artikel
55 Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis Meletta, Romana
2017
72-73 C p. 31-43
artikel
56 [11C]AZ10419096 – a full antagonist PET radioligand for imaging brain 5-HT1B receptors Lindberg, Anton
2017
72-73 C p. 34-40
7 p.
artikel
57 Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer Su, Shu

72-73 C p. 76-83
artikel
58 [11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice Traxl, Alexander
2017
72-73 C p. 7-15
9 p.
artikel
59 Characterization of actinide resin for separation of 51,52gMn from bulk target material Barrett, Kendall E.

72-73 C p. 19-26
artikel
60 Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours Gaertner, F.C.

72-73 C p. 1-9
artikel
61 Clinical 68Ga-PET: Is radiosynthesis module an absolute necessity? Chakravarty, Rubel
2017
72-73 C p. 1-11
11 p.
artikel
62 Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer Evangelista, Laura
2017
72-73 C p. 47-49
artikel
63 Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy Chakravarty, Rubel
2019
72-73 C p. 1-10
artikel
64 Clinical translation of a PSMA inhibitor for 99mTc-based SPECT Ferro-Flores, Guillermina
2017
72-73 C p. 36-44
9 p.
artikel
65 Clinical usefulness of 18F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis Lefebvre, Nicolas
2017
72-73 C p. 17-24
artikel
66 Combination radionuclide therapy: A new paradigm Suman, Shishu Kant

72-73 C p. 40-58
artikel
67 Commentary Eckelman, William C.
2017
72-73 C p. 1-3
3 p.
artikel
68 Comparative evaluation of [18F]DiFA and its analogs as novel hypoxia positron emission tomography and [18F]FMISO as the standard Nakata, Norihito
2019
72-73 C p. 39-45
artikel
69 Comparison between [18F]fluorination and [18F]fluoroethylation reactions for the synthesis of the PDE10A PET radiotracer [18F]MNI-659 Mori, Wakana
2017
72-73 C p. 12-18
artikel
70 Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches Feiner, Irene V.J.

72-73 C p. 24-33
artikel
71 Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold Kaeopookum, Piriya

72-73 C p. 1-10
artikel
72 Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model Green, Michael V.
2017
72-73 C p. 29-36
8 p.
artikel
73 Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells Garg, Ravendra

72-73 C p. 80-88
artikel
74 Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation Krohn, Kenneth A.

72-73 C p. 5-23
artikel
75 Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight Coenen, Heinz H.
2017
72-73 C p. v-xi
artikel
76 Contents
72-73 C p. OBC
artikel
77 Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies Amor-Coarasa, Alejandro
2017
72-73 C p. 37-39
3 p.
artikel
78 Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue Parente, Andrea
2017
72-73 C p. 50-56
artikel
79 Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy? Chia, Kazumi

72-73 C p. 10-17
artikel
80 Corrigendum to “131I-labeled chitosan hydrogels for radioembolization: a preclinical study in small animals” [Nucl Med Biol 52 (2017) 16–23] Hwang, Hyosook
2018
72-73 C p. 50
artikel
81 Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73] Kasten, Benjamin B.
2018
72-73 C p. 71
artikel
82 Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] Stergiou, N.

72-73 C p. 65
artikel
83 [11C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain Vidal, Benjamin
2017
72-73 C p. 1-6
artikel
84 [11C]phosgene: Synthesis and application for development of PET radiotracers Fukumura, Toshimitsu

72-73 C p. 138-148
artikel
85 Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV Sinharay, Sanhita
2017
72-73 C p. 27-33
artikel
86 Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology Stegmayr, Carina

72-73 C p. 78-84
artikel
87 Cyclotron production of 68Ga in a liquid target: Effects of solution composition and irradiation parameters Pandey, Mukesh K.

72-73 C p. 49-55
artikel
88 Cyclotron production of 99mTc Gumiela, Magdalena
2018
72-73 C p. 33-41
artikel
89 Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT Jiang, Donglang

72-73 C p. 89-95
artikel
90 Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters Rosenkranz, Andrey A.

72-73 C p. 45-56
artikel
91 Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11 Svedjehed, Johan

72-73 C p. 1-10
artikel
92 Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue Goos, Jeroen A.C.M.

72-73 C p. 63-72
artikel
93 Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors Lever, John R.
2019
72-73 C p. 53-66
artikel
94 Detection of melanoma metastases with PET—Comparison of 18F-5-FPN with 18F–FDG Wang, Yichun
2017
72-73 C p. 33-38
artikel
95 Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent Liu, Futao
2018
72-73 C p. 42-49
artikel
96 Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a) Kawamura, Kazunori
2017
72-73 C p. 49-56
8 p.
artikel
97 Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2 Ma, Li

72-73 C p. 61-69
artikel
98 Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications Klasen, Benedikt

72-73 C p. 12-23
artikel
99 Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations Radzik, Marcin

72-73 C p. 63-73
artikel
100 Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096 Lindberg, Anton

72-73 C p. 11-16
artikel
101 Development of a novel radiobromine-labeled sigma-1 receptor imaging probe Ogawa, Kazuma
2018
72-73 C p. 28-35
artikel
102 Development of a PET radioligand selective for cerebral amyloid angiopathy Abrahamson, Eric E.

72-73 C p. 85-96
artikel
103 Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At Crawford, Jason R.
2017
72-73 C p. 31-35
5 p.
artikel
104 Development of a thin layer chromatography method for plasma correction of [18F]fluorocholine metabolites in positron emission tomography quantification studies in humans Villar, Marina

72-73 C p. 34-40
artikel
105 Development of [11C]/[3H]THK-5351 – A potential novel carbon-11 tau imaging PET radioligand Stepanov, Vladimir
2017
72-73 C p. 50-53
4 p.
artikel
106 Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands Bongarzone, Salvatore
2019
72-73 C p. 14-21
artikel
107 Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase van der Wildt, Berend
2017
72-73 C p. 90-104
15 p.
artikel
108 Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes Saito, Kosuke

72-73 C p. 72-79
artikel
109 Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma Zhu, Wen Jing
2018
72-73 C p. 16-21
artikel
110 Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers Kumar, Dheeraj

72-73 C p. 1-10
artikel
111 Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates Stepanov, Vladimir
2018
72-73 C p. 12-19
artikel
112 (1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection de Sousa Lacerda, Camila Maria
2017
72-73 C p. 19-24
6 p.
artikel
113 Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells Kobayashi, Masato
2017
72-73 C p. 78-82
5 p.
artikel
114 Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation Wang, Jing

72-73 C p. 46-52
artikel
115 Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold He, Yingfang

72-73 C p. 24-32
artikel
116 Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy Bastiani, Isabella

72-73 C p. 10-20
artikel
117 Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system Matesic, Lidia
2017
72-73 C p. 24-31
8 p.
artikel
118 DOTA-tetrazine probes with modified linkers for tumor pretargeting Läppchen, Tilman
2017
72-73 C p. 19-26
artikel
119 Do we say what we mean and mean what we say? Coenen, Heinz H.
2017
72-73 C p. 53-54
2 p.
artikel
120 Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer Staniszewska, Magdalena

72-73 C p. 101-111
artikel
121 Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours Knight, James C.
2019
72-73 C p. 14-22
artikel
122 Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs de Lange, Charlotte
2018
72-73 C p. 49-57
artikel
123 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
124 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
125 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
126 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
127 Editorial Board 2018
72-73 C p. IFC
artikel
128 Editorial Board 2018
72-73 C p. IFC
artikel
129 Editorial Board 2019
72-73 C p. ii
artikel
130 Editorial Board 2018
72-73 C p. IFC
artikel
131 Editorial Board 2018
72-73 C p. IFC
artikel
132 Editorial Board 2019
72-73 C p. ii
artikel
133 Editorial Board 2019
72-73 C p. ii
artikel
134 Editorial Board 2019
72-73 C p. ii
artikel
135 Editorial Board
72-73 C p. ii
artikel
136 Editorial Board
72-73 C p. ii
artikel
137 Editorial Board
72-73 C p. ii
artikel
138 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
139 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
140 Editorial Board 2018
72-73 C p. IFC
artikel
141 Editorial Board 2018
72-73 C p. IFC
artikel
142 Editorial Board 2018
72-73 C p. IFC
artikel
143 Editorial Board
72-73 C p. IFC
artikel
144 Editorial Board
72-73 C p. IFC
artikel
145 Editorial Board 2017
72-73 C p. IFC
artikel
146 Editorial Board 2017
72-73 C p. IFC
artikel
147 Editorial Board 2017
72-73 C p. IFC
artikel
148 Editorial Board 2018
72-73 C p. IFC
artikel
149 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
150 Editorial Board 2017
72-73 C p. IFC-
1 p.
artikel
151 Editorial Board 2017
72-73 C p. IFC
artikel
152 Editorial Board
72-73 C p. ii
artikel
153 Editorial Board
72-73 C p. ii
artikel
154 Editorial Board
72-73 C p. ii
artikel
155 Editorial Board
72-73 C p. ii
artikel
156 Editorial Board
72-73 C p. ii
artikel
157 Editorial Board
72-73 C p. ii
artikel
158 Editorial Board
72-73 C p. ii
artikel
159 Editorial Board
72-73 C p. ii
artikel
160 Editorial Board
72-73 C p. ii
artikel
161 Editorial Board
72-73 C p. ii
artikel
162 Editorial Board
72-73 C p. ii
artikel
163 Editorial Board
72-73 C p. ii
artikel
164 Editorial Board
72-73 C p. ii
artikel
165 Editorial Board
72-73 C p. ii
artikel
166 Editorial Board
72-73 C p. ii
artikel
167 Editorial Board
72-73 C p. ii
artikel
168 Editorial Board
72-73 C p. ii
artikel
169 Editorial Board
72-73 C p. ii
artikel
170 Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR Chan, Conrad

72-73 C p. 37-44
artikel
171 Effect of methoxy group position on biological properties of 18F–labeled benzyl triphenylphosphonium cations Chen, Shuting
2017
72-73 C p. 16-23
artikel
172 Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE Rousseau, Etienne
2018
72-73 C p. 10-17
artikel
173 Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands Tago, Tetsuro

72-73 C p. 38-45
artikel
174 Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation Keinänen, Outi
2018
72-73 C p. 27-35
artikel
175 Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid Kanai, Ayaka

72-73 C p. 47-52
artikel
176 Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe Hamamatsu, Keita

72-73 C p. 22-27
artikel
177 Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer Green, Mark A.
2017
72-73 C p. 32-35
4 p.
artikel
178 Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma Cortez, Angel

72-73 C p. 62-72
artikel
179 Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin Graves, Stephen A.

72-73 C p. 1-7
artikel
180 Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and 177Lu labeling Altai, Mohamed
2017
72-73 C p. 1-9
9 p.
artikel
181 Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26 Mansour, Nematallah
2018
72-73 C p. 31-38
artikel
182 Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system Wilson, Alan A.
2017
72-73 C p. 14-20
7 p.
artikel
183 Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac Bailey, Tyler A.

72-73 C p. 28-36
artikel
184 Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma Vermeulen, Koen

72-73 C p. 1-11
artikel
185 Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer Carlucci, Giuseppe
2017
72-73 C p. 9-15
7 p.
artikel
186 Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer Jiang, Hao
2019
72-73 C p. 36-44
artikel
187 Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats Salabert, Anne-Sophie
2018
72-73 C p. 1-8
artikel
188 Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function Yagi, Yusuke

72-73 C p. 25-31
artikel
189 Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII Fiedler, L.
2018
72-73 C p. 55-62
artikel
190 Evaluation of N-(6-[18F]Fluoropyridin-3-yl)glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy Wang, Hongliang

72-73 C p. 59-65
artikel
191 Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer. Li, Yawen

72-73 C p. 217-227
artikel
192 Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors Honarvar, Hadis
2017
72-73 C p. 15-21
7 p.
artikel
193 Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors Abreu Diaz, Aida M.

72-73 C p. 41-49
artikel
194 Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA Pretze, Marc
2017
72-73 C p. 35-42
8 p.
artikel
195 Excitation function and yield for the 103Rh(d,2n)103Pd nuclear reaction: Optimization of the production of palladium-103 Manenti, Simone
2017
72-73 C p. 30-37
artikel
196 Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging Tang, Caihua

72-73 C p. 55-62
artikel
197 EXIRAD-3D: Fast automated three-dimensional autoradiography Nguyen, Minh Phuong

72-73 C p. 59-65
artikel
198 Expanding LogP: Present possibilities Vraka, Chrysoula
2018
72-73 C p. 20-32
artikel
199 Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18 Coenen, Heinz H.

72-73 C p. 241-269
artikel
200 Facile radiochemical separation of clinical-grade 90Y from 90Sr by selective precipitation for targeted radionuclide therapy Chakravarty, Rubel
2019
72-73 C p. 58-65
artikel
201 Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[18F]fluoropropyl)benzylguanidine ([18F]mFPBG) Woo, Sang-Keun
2018
72-73 C p. 63-70
artikel
202 Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain Fuchigami, Takeshi

72-73 C p. 41-48
artikel
203 [18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease Keller, Thomas
2018
72-73 C p. 1-9
artikel
204 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation Verhoeven, Jeroen

72-73 C p. 9-16
artikel
205 18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury Rodrigues, Rosana S.
2017
72-73 C p. 52-62
11 p.
artikel
206 [18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO Zhou, Weiyan
2018
72-73 C p. 45-55
artikel
207 18F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer Xu, Duo
2018
72-73 C p. 48-55
artikel
208 18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer Gao, Fei
2019
72-73 C p. 62-69
artikel
209 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation Kirjavainen, Anna K.
2018
72-73 C p. 39-46
artikel
210 18F-Labeled perfluorocarbon droplets for positron emission tomography imaging Amir, Nagina
2017
72-73 C p. 27-33
7 p.
artikel
211 18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging Kwon, Young-Do

72-73 C p. 22-36
artikel
212 Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain Zhang, Yan
2018
72-73 C p. 1-9
artikel
213 Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging Demétrio de Souza França, Paula

72-73 C p. 80-87
artikel
214 Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate Sundaram, G.S.M.

72-73 C p. 33-40
artikel
215 From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience Pouget, Jean-Pierre

72-73 C p. 53-64
artikel
216 [18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4 Amor-Coarasa, Alejandro
2018
72-73 C p. 37-44
artikel
217 GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726 Nguyen, Van T.

72-73 C p. 44-51
artikel
218 [68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT Kroiss, Alexander Stephan
2019
72-73 C p. 47-53
artikel
219 68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents Sivapackiam, Jothilingam
2018
72-73 C p. 29-35
artikel
220 [68Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent Shi, Shengyu

72-73 C p. 17-24
artikel
221 [68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging Rivera-Bravo, Belén

72-73 C p. 54-60
artikel
222 [68Ga]Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma Zhang, Pengjun

72-73 C p. 19-24
artikel
223 67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes Ioppolo, Joseph A.
2017
72-73 C p. 32-41
10 p.
artikel
224 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics Mittal, Sweety

72-73 C p. 61-67
artikel
225 68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma Li, Linlin

72-73 C p. 87-96
artikel
226 68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging Chen, Chien-Jen
2019
72-73 C p. 22-30
artikel
227 Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent Bhatt, Jyotsna

72-73 C p. 47-53
artikel
228 [68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair Nader, M.

72-73 C p. 37-44
artikel
229 Gefitinib enhances radiotherapeutic effects of 131I–hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts Xia, Lu
2017
72-73 C p. 63-68
6 p.
artikel
230 GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study Velikyan, Irina

72-73 C p. 73-85
artikel
231 Gold nanoparticles meet medical radionuclides Daems, Noami

72-73 C p. 61-90
artikel
232 Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET Andersen, Katrine B.

72-73 C p. 52-58
artikel
233 High-throughput radio-TLC analysis Wang, Jia

72-73 C p. 41-48
artikel
234 HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study Follacchio, Giulia Anna

72-73 C p. 94-100
artikel
235 HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging Li, Ai-Mei

72-73 C p. 27-34
artikel
236 Human biodistribution and dosimetry of [18F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer Betthauser, Tobey J.
2017
72-73 C p. 7-11
artikel
237 Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine Frisch, Kim
2019
72-73 C p. 55-61
artikel
238 Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM Igarashi, Chika

72-73 C p. 10-15
artikel
239 131I-labeled chitosan hydrogels for radioembolization: A preclinical study in small animals Hwang, Hyosook
2017
72-73 C p. 16-23
8 p.
artikel
240 Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction Liu, Zhonglin
2019
72-73 C p. 67-77
artikel
241 Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution Bongarzone, Salvatore

72-73 C p. 24-33
artikel
242 Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model Houson, Hailey A.
2018
72-73 C p. 9-15
artikel
243 Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids Park, Ji Yong

72-73 C p. 28-35
artikel
244 Imaging thrombosis with 99mTc-labeled RAM.1-antibody in vivo Ouadi, Ali
2018
72-73 C p. 21-27
artikel
245 [131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma Kobayashi, Masato

72-73 C p. 49-54
artikel
246 Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides Xu, Dong
2017
72-73 C p. 1-8
8 p.
artikel
247 Immuno-imaging of ICAM-1 in tumours by SPECT Mosley, Michael

72-73 C p. 73-79
artikel
248 Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma Wen, Xuejun

72-73 C p. 44-51
artikel
249 Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents Tietz, Ole

72-73 C p. 9-17
artikel
250 Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation Ellison, Paul A.

72-73 C p. 32-36
artikel
251 Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons Kurakina, E.S.

72-73 C p. 22-27
artikel
252 Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging Ruivo, Eduardo

72-73 C p. 36-42
artikel
253 Improving metabolic stability of fluorine-18 labeled verapamil analogs Raaphorst, Renske M.

72-73 C p. 47-56
artikel
254 111In-DTPA-d-Phe−1-Asp0-d-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-d-Phe1-octreotide Oshima, Nobuhiro
2017
72-73 C p. 18-26
9 p.
artikel
255 Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor Schneider, Daniela

72-73 C p. 1-8
artikel
256 Influence of transport line material on the molar activity of cyclotron produced [18F]fluoride Savisto, Nina

72-73 C p. 8-15
artikel
257 Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals Jörg, G.
2017
72-73 C p. 105-113
9 p.
artikel
258 Intraarticular and intravenous administration of 99MTc-HMPAO-labeled human mesenchymal stem cells ( 99M TC-AH-MSC S ): In vivo imaging and biodistribution Meseguer-Olmo, Luis
2017
72-73 C p. 36-42
7 p.
artikel
259 Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines Delbart, Wendy

72-73 C p. 68-79
artikel
260 Investigation of 123I production using electron accelerator Avetisyan, Albert
2017
72-73 C p. 44-47
artikel
261 In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector Läppchen, Tilman
2018
72-73 C p. 45-54
artikel
262 In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain Kilbourn, Michael R.

72-73 C p. 38-42
artikel
263 In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab Othman, Muhamad Faiz bin

72-73 C p. 57-64
artikel
264 In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate Yamasaki, Kazuaki
2018
72-73 C p. 21-25
artikel
265 In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model Jiao, Honglei
2019
72-73 C p. 31-39
artikel
266 In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration Patel, Shil

72-73 C p. 20-30
artikel
267 Is logP truly dead? Kilbourn, Michael R.
2017
72-73 C p. 41-42
2 p.
artikel
268 Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibility Kilbourn, Michael R.
2018
72-73 C p. 52-55
artikel
269 Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals Klenner, Mitchell A.

72-73 C p. 112-147
artikel
270 Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713 Yasuno, Fumihiko

72-73 C p. 76-84
artikel
271 Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators Hong, Haiyan

72-73 C p. 1-9
artikel
272 Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy O'Neill, Edward

72-73 C p. 44-53
artikel
273 Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate Zhou, Zhengyuan

72-73 C p. 24-35
artikel
274 LogP, a yesterday's value? Vraka, Chrysoula
2017
72-73 C p. 1-10
artikel
275 Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of 131I-labeling Wagener, Karolin
2018
72-73 C p. 59-66
artikel
276 Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer Bandara, Nilantha

72-73 C p. 71-77
artikel
277 Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors Kong, Ziren

72-73 C p. 80-87
artikel
278 Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides Costa, Ines M.

72-73 C p. 18-29
artikel
279 MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons Xu, Yingjiao

72-73 C p. 9-18
artikel
280 Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors Lisova, Ksenia
2018
72-73 C p. 36-44
artikel
281 Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity Chegu, Anusha

72-73 C p. 70-75
artikel
282 Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders Brandt, Marie
2019
72-73 C p. 46-52
artikel
283 Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands Winter, Gordon
2019
72-73 C p. 20-25
artikel
284 Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method Pichler, Verena
2018
72-73 C p. 21-26
artikel
285 Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras Jiao, Yuying

72-73 C p. 28-37
artikel
286 Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease Giron, Maria Cecilia

72-73 C p. 72-77
artikel
287 Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET Wagner, Michael
2018
72-73 C p. 51-58
artikel
288 Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system Yoo, Ran Ji
2017
72-73 C p. 45-51
7 p.
artikel
289 Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: Radiosynthesis and evaluation as potential renal tubular tracers Lipowska, Malgorzata
2017
72-73 C p. 48-55
artikel
290 [99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference Palmieri, Luca
2018
72-73 C p. 1-9
artikel
291 99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging Rezazadeh, Farzaneh

72-73 C p. 54-62
artikel
292 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients Santos-Cuevas, Clara
2017
72-73 C p. 1-6
6 p.
artikel
293 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen Xu, Xiaoping
2017
72-73 C p. 69-75
7 p.
artikel
294 99mTc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn Zhang, Xin
2017
72-73 C p. 44-49
artikel
295 [99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy Li, Yi
2018
72-73 C p. 18-25
artikel
296 [99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas Vallejo-Armenta, Paola

72-73 C p. 1-8
artikel
297 Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer Sarparanta, Mirkka

72-73 C p. 1-12
artikel
298 Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy Piotrowska, Agata
2017
72-73 C p. 10-18
artikel
299 Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets Kim, Junghyun
2017
72-73 C p. 42-48
7 p.
artikel
300 Neutron-activated theranostic radionuclides for nuclear medicine Tan, Hun Yee

72-73 C p. 55-68
artikel
301 New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles Moiseeva, A.N.

72-73 C p. 52-61
artikel
302 New potent A1 adenosine receptor radioligands for positron emission tomography Kreft, Sabrina
2017
72-73 C p. 69-77
9 p.
artikel
303 News ways of understanding the complex biology of diabetes using PET Eriksson, O.

72-73 C p. 65-71
artikel
304 N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in rats Frisch, Kim
2018
72-73 C p. 56-62
artikel
305 N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic Schmitt, Sébastien
2017
72-73 C p. 50-61
12 p.
artikel
306 Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model Bansal, Aditya

72-73 C p. 4-11
artikel
307 Noninvasively visualize the expression of LAPTM4B protein using a novel 18F-labeled peptide PET probe in hepatocellular carcinoma Ren, Yunyan

72-73 C p. 52-60
artikel
308 [No title] Gott, Matthew

72-73 C p. 32
artikel
309 Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta) Meijer, Lisette

72-73 C p. 1-8
artikel
310 Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers Blevins, David W.

72-73 C p. 41-48
artikel
311 Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation Teyssier, Valentin R.

72-73 C p. 34-44
artikel
312 Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution Egorova, B.V.
2018
72-73 C p. 1-10
artikel
313 Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas Watanabe, Hiroyuki

72-73 C p. 93-97
artikel
314 Nuclear data for production and medical application of radionuclides: Present status and future needs Qaim, Syed M.
2017
72-73 C p. 31-49
19 p.
artikel
315 O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human Imperiale, Alessio
2017
72-73 C p. 21-28
8 p.
artikel
316 On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling Socan, A.
2019
72-73 C p. 23-31
artikel
317 One-pot enzymatic synthesis of l-[3-11C]lactate for pharmacokinetic analysis of lactate metabolism in rat brain Temma, Takashi

72-73 C p. 28-33
artikel
318 One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging Basuli, Falguni

72-73 C p. 63-70
artikel
319 One-step 18F-fluorination of smart positron emission tomography tracer for sensing furin activity in tumors Zhao, Xueyu

72-73 C p. 72-79
artikel
320 On the applicability of [18F]FBPA to predict L-BPA concentration after amino acid preloading in HuH-7 liver tumor model and the implication for liver boron neutron capture therapy Grunewald, Catrin
2017
72-73 C p. 83-89
7 p.
artikel
321 On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion Herth, Matthias M.

72-73 C p. 19-21
artikel
322 Optimization of solid-phase extraction (SPE) in the preparation of [18F]D3FSP: A new PET imaging agent for mapping Aβ plaques Yao, Xinyue
2019
72-73 C p. 54-64
artikel
323 Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine Ohshima, Yasuhiro

72-73 C p. 44-51
artikel
324 Outside Back Cover
72-73 C p. OBC
artikel
325 Outside Back Cover
72-73 C p. OBC
artikel
326 Outside Back Cover
72-73 C p. OBC
artikel
327 Outside Back Cover
72-73 C p. OBC
artikel
328 Outside Back Cover
72-73 C p. OBC
artikel
329 Outside Back Cover
72-73 C p. OBC
artikel
330 Outside Back Cover
72-73 C p. OBC
artikel
331 Outside Back Cover - Graphical abstract TOC
72-73 C p. OBC
artikel
332 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
333 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
334 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
335 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
336 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
337 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
338 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
339 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
340 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
72-73 C p. OBC
artikel
341 Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours Geenen, Lorain

72-73 C p. 1-11
artikel
342 Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity Seo, Daniele
2017
72-73 C p. 57-64
artikel
343 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models Kasten, Benjamin B.
2018
72-73 C p. 67-73
artikel
344 Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy Bongarzone, Salvatore

72-73 C p. 66-67
artikel
345 PET [11C]acetate is also a perfusion tracer for kidney evaluation purposes Normand, Gabrielle

72-73 C p. 10-14
artikel
346 PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients Calabria, Ferdinando
2017
72-73 C p. 40-54
15 p.
artikel
347 PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs Wong, Patty
2017
72-73 C p. 62-68
artikel
348 PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data Tang, Jie

72-73 C p. 1-9
artikel
349 PET measurement of “GABA shift” in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil Kim, Wook
2017
72-73 C p. 30-34
5 p.
artikel
350 PET studies in non-human primates: Choosing drug doses Kilbourn, Michael R.
2017
72-73 C p. 1-3
artikel
351 Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex Mairinger, Severin

72-73 C p. 28-32
artikel
352 p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide H.A. Kankanamalage, Pavithra

72-73 C p. 1-9
artikel
353 Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations Filosofov, Dmitry

72-73 C p. 1-19
artikel
354 Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb Fiaccabrino, Desiree Erika

72-73 C p. 81-91
artikel
355 Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase Estrada, Sergio

72-73 C p. 62-71
artikel
356 Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model Lien, Vegard Torp

72-73 C p. 74-80
artikel
357 Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain Zha, Zhihao

72-73 C p. 97-106
artikel
358 Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats Matsusaka, Yohji
2018
72-73 C p. 26-30
artikel
359 Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice Aghevlian, Sadaf

72-73 C p. 8-17
artikel
360 Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model Ohshima, Yasuhiro

72-73 C p. 15-22
artikel
361 Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis Higashikawa, Kei

72-73 C p. 25-32
artikel
362 Preclinical study of an 18F-labeled glutamine derivative for cancer imaging Li, Cong

72-73 C p. 34-40
artikel
363 Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue Emery, Stéphane

72-73 C p. 57-63
artikel
364 Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155 Mitsuoka, Keisuke

72-73 C p. 41-46
artikel
365 Preferred use of curie (ci) rather than becquerel (Bq) in nuclear medicine practice Pillai, Maroor Raghavan Ambikalmajan
2017
72-73 C p. 51-52
2 p.
artikel
366 Pre-labelling versus direct labelling of anthrax proteins for imaging of matrix metalloproteinases activity using DOTA-GA Xavier, Mary-Ann Elvina
2019
72-73 C p. 49-54
artikel
367 Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer Zhou, Dong
2018
72-73 C p. 26-31
artikel
368 Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma Roxin, Áron
2018
72-73 C p. 11-20
artikel
369 Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab Azadbakht, Bakhtiar
2017
72-73 C p. 26-30
5 p.
artikel
370 Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases Tang, Tang
2017
72-73 C p. 10-17
8 p.
artikel
371 Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis Erfani, Mostafa
2017
72-73 C p. 1-7
artikel
372 Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb Jakobsson, Ulrika

72-73 C p. 102-110
artikel
373 Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate Lee, Ji Youn

72-73 C p. 38-45
artikel
374 Preparation of [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies Guleria, Mohini

72-73 C p. 31-40
artikel
375 Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution Westrøm, Sara
2017
72-73 C p. 1-9
9 p.
artikel
376 Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography Chen, Junyi

72-73 C p. 54-60
artikel
377 Production of Zr-89 using sputtered yttrium coin targets Queern, Stacy Lee
2017
72-73 C p. 11-16
artikel
378 Production, purification and availability of 211At: Near term steps towards global access Feng, Yutian

72-73 C p. 12-23
artikel
379 Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine Schillaci, Orazio
2019
72-73 C p. 66-79
artikel
380 Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development Radchenko, Valery
2017
72-73 C p. 25-32
artikel
381 Quantitation of rat cerebral blood flow using 99mTc-HMPAO Suzuki, Chie
2017
72-73 C p. 19-22
artikel
382 Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody Nakata, Norihito

72-73 C p. 33-43
artikel
383 Radiation dosimetry of [18F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolism Lee, Narae
2019
72-73 C p. 45-48
artikel
384 Radiation induced oxidation of [18F]fluorothia fatty acids under cGMP manufacturing conditions Pandey, Mukesh K.

72-73 C p. 13-23
artikel
385 Radioarsenic: A promising theragnostic candidate for nuclear medicine Sanders, Vanessa A.

72-73 C p. 184-201
artikel
386 Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma Sobral, Danielle V.

72-73 C p. 14-23
artikel
387 Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib Boyle, Amanda J.

72-73 C p. 46-54
artikel
388 Radiolabeling and biological characterization of TPGS-based nanomicelles by means of small animal imaging Tesan, Fiorella Carla
2017
72-73 C p. 62-68
7 p.
artikel
389 Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu Shalgunov, Vladimir

72-73 C p. 11-21
artikel
390 Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results Imura, Ryota

72-73 C p. 21-28
artikel
391 Radiolabeling with [11C]HCN for Positron emission tomography Zhou, Yu-Peng

72-73 C p. 56-86
artikel
392 Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1 Rosestedt, Maria

72-73 C p. 54-62
artikel
393 Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy Nelson, Bryce J.B.

72-73 C p. 59-66
artikel
394 Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles Pozzi, Oscar R.
2017
72-73 C p. 43-49
7 p.
artikel
395 Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation Nemieboka, Brandon

72-73 C p. 9-19
artikel
396 Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors Sun, Penghui

72-73 C p. 1-9
artikel
397 Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging Tang, Caihua
2017
72-73 C p. 39-46
artikel
398 Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1 Huang, Tianyu

72-73 C p. 18-27
artikel
399 Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands Willmann, Michael

72-73 C p. 43-52
artikel
400 Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging Wang, Hongliang

72-73 C p. 98-105
artikel
401 Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins Bai, Ping

72-73 C p. 96-101
artikel
402 Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine Baguet, Tristan

72-73 C p. 20-29
artikel
403 Rapid and automated production of [68Ga]gallium chloride and [68Ga]Ga-DOTA-TATE on a medical cyclotron Tieu, William

72-73 C p. 12-18
artikel
404 Rapid detection of SARS-CoV-2 using a radiolabeled antibody Pirovano, Giacomo

72-73 C p. 69-75
artikel
405 Reactive oxygen species-driven HIF1α triggers accelerated glycolysis in endothelial cells exposed to low oxygen tension Paik, Jin-Young
2017
72-73 C p. 8-14
7 p.
artikel
406 Re-assessing gallium-67 as a therapeutic radionuclide Othman, Muhamad F. bin
2017
72-73 C p. 12-18
7 p.
artikel
407 Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals Piron, Sarah

72-73 C p. 29-51
artikel
408 Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation Lipowska, Malgorzata
2018
72-73 C p. 42-50
artikel
409 Reconsider logP! Vraka, Chrysoula
2017
72-73 C p. 42-
1 p.
artikel
410 Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity Oshima, Nobuhiro
2017
72-73 C p. 16-25
10 p.
artikel
411 Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO Nakajima, Kohei

72-73 C p. 85-92
artikel
412 Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18F]FBEM and in vivo PET studies Dammicco, Sylvestre
2017
72-73 C p. 33-39
7 p.
artikel
413 Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake Kagawa, Shinya
2017
72-73 C p. 8-15
artikel
414 Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides Arano, Yasushi

72-73 C p. 149-155
artikel
415 Review on 99mTc radiopharmaceuticals with emphasis on new advancements Duatti, Adriano

72-73 C p. 202-216
artikel
416 Review: PET imaging with macro- and middle-sized molecular probes Mukai, Hidefumi

72-73 C p. 156-170
artikel
417 Robust high-yield ~1 TBq production of cyclotron based sodium [99mTc]pertechnetate Andersson, J.D.
2018
72-73 C p. 63-70
artikel
418 Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy Xu, Qinfeng

72-73 C p. 34-43
artikel
419 Semi-automated system for concentrating 68Ga-eluate to obtain high molar and volume concentration of 68Ga-Radiopharmaca for preclinical applications de Blois, Erik

72-73 C p. 16-21
artikel
420 Sex-differences in [68Ga]Ga-DOTANOC biodistribution Leisser, A.

72-73 C p. 15-20
artikel
421 Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer Sun, Aixia
2017
72-73 C p. 38-43
artikel
422 Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia – Multimodal imaging assessment Goggi, Julian Luke
2017
72-73 C p. 25-31
7 p.
artikel
423 Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent Feng, Yutian

72-73 C p. 171-183
artikel
424 Small-scale production of 67Cu for a preclinical study via the 64Ni(α, p)67Cu channel Ohya, Tomoyuki
2018
72-73 C p. 56-60
artikel
425 Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes Makris, George
2019
72-73 C p. 39-46
artikel
426 Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers Nics, Lukas
2018
72-73 C p. 28-33
artikel
427 Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy Radchenko, Valery

72-73 C p. 106
artikel
428 Status of radiobiology in molecular radionuclide therapy – Hope for the future Nonnekens, Julie

72-73 C p. 45-46
artikel
429 Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative Coenen, Heinz H.
2019
72-73 C p. 19-22
artikel
430 Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2 Luo, Zonghua

72-73 C p. 52-61
artikel
431 Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors Mikaeili, Azadeh
2017
72-73 C p. 10-17
8 p.
artikel
432 Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors Radford, Lauren
2017
72-73 C p. 4-9
artikel
433 Synthesis and evaluation of an N-[18F]fluorodeoxyglycosyl amino acid for PET imaging of tumor metabolism Wu, Zhifang
2018
72-73 C p. 40-48
artikel
434 Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor Zha, Zhihao
2018
72-73 C p. 36-47
artikel
435 Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia Pees, Anna

72-73 C p. 97-105
artikel
436 Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO) Qiao, Zheng

72-73 C p. 1-10
artikel
437 Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging Li, Xueli

72-73 C p. 84-92
artikel
438 Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX Nakashima, Kazuma

72-73 C p. 46-53
artikel
439 Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter Das, Soumen
2019
72-73 C p. 49-57
artikel
440 Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting Paparidis, Georgios
2018
72-73 C p. 34-41
artikel
441 Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease Lerdsirisuk, Pradith

72-73 C p. 11-18
artikel
442 Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors Lindberg, Anton
2019
72-73 C p. 1-13
artikel
443 Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging Jacobsen, Christian Borch

72-73 C p. 49-56
artikel
444 Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer Kwan, Kim H.

72-73 C p. 37-45
artikel
445 Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5 Rotteveel, Lonneke

72-73 C p. 9-19
artikel
446 Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass Eriksson, Jonas
2019
72-73 C p. 1-10
artikel
447 Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer Vaidyanathan, Ganesan

72-73 C p. 67-80
artikel
448 Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides Sanders, Vanessa A.
2019
72-73 C p. 1-13
artikel
449 Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors Prause, Martin
2018
72-73 C p. 1-11
artikel
450 Synthesis of 11C-labeled DNA polymerase-β inhibitor 5-methoxyflavone and PET/CT imaging thereof Chen, Zude

72-73 C p. 17-22
artikel
451 Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors Arisawa, Tetsu

72-73 C p. 47-58
artikel
452 Synthesis of N-(6-[18F]Fluoropyridin-3-yl)glycine as a potential renal PET agent Wang, Hongliang

72-73 C p. 21-27
artikel
453 Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor Klein, Pieter J.
2017
72-73 C p. 25-32
8 p.
artikel
454 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
455 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
456 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
457 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
458 Table Of Contents 2018
72-73 C p. IBC
artikel
459 Table of Contents 2018
72-73 C p. IBC
artikel
460 Table of Contents 2018
72-73 C p. IBC
artikel
461 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
462 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
463 Table of Contents 2018
72-73 C p. IBC
artikel
464 Table of Contents
72-73 C p. IBC
artikel
465 Table of Contents
72-73 C p. IBC
artikel
466 Table of Contents 2018
72-73 C p. IBC
artikel
467 Table of Contents 2017
72-73 C p. IBC
artikel
468 Table of Contents 2018
72-73 C p. IBC
artikel
469 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
470 Table of Contents 2017
72-73 C p. IBC-
1 p.
artikel
471 Table of Contents 2017
72-73 C p. IBC
artikel
472 Table of Contents 2017
72-73 C p. IBC
artikel
473 Table of Contents 2017
72-73 C p. IBC
artikel
474 Table of Contents & Barcode 2018
72-73 C p. IBC
artikel
475 Table of Contents & Barcode 2018
72-73 C p. IBC
artikel
476 Tactics for preclinical validation of receptor-binding radiotracers Lever, Susan Z.
2017
72-73 C p. 4-30
27 p.
artikel
477 Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers Nelson, Bryce J.B.

72-73 C p. 24-31
artikel
478 Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals Rigby, Alex

72-73 C p. 1-7
artikel
479 Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer Li, Junling

72-73 C p. 23-30
artikel
480 Target manufacturing by Spark Plasma Sintering for efficient 89Zr production Cisternino, S.

72-73 C p. 38-46
artikel
481 The development of 11C-carbonylation chemistry: A systematic view Eriksson, Jonas

72-73 C p. 115-137
artikel
482 The effect of hypoxia on the induction of strand breaks in plasmid DNA by alpha-, beta- and Auger electron-emitters 223Ra, 188Re, 99mTc and DNA-binding 99mTc-labeled pyrene Reissig, Falco

72-73 C p. 65-70
artikel
483 The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy Aloj, Luigi

72-73 C p. 53-64
artikel
484 The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates Jiang, Wen

72-73 C p. 1-8
artikel
485 The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence Reissig, Falco

72-73 C p. 59-68
artikel
486 The past, present, and the promise of the future of nuclear medicine and biology Eckelman, W.C.
2017
72-73 C p. 47-48
artikel
487 The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review Katzenellenbogen, John A.

72-73 C p. 24-37
artikel
488 The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far Heynickx, Nathalie

72-73 C p. 30-39
artikel
489 Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy Spetz, Johan
2018
72-73 C p. 11-18
artikel
490 45Ti targeted tracers for PET imaging of PSMA Chaple, Ivis F.

72-73 C p. 16-23
artikel
491 Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies Driver, Cathryn Helena Stanford

72-73 C p. 53-66
artikel
492 Training the next generation of radiopharmaceutical scientists Gee, Antony D.

72-73 C p. 10-13
artikel
493 Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells Kobayashi, Masato

72-73 C p. 33-37
artikel
494 Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1 Al-saden, Noor
2018
72-73 C p. 43-51
artikel
495 Unexpected decrease in in vivo binding of [3H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [11C]NMPB Inoue, Osamu
2018
72-73 C p. 15-20
artikel
496 Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage Suzuki, Motofumi

72-73 C p. 45-55
artikel
497 Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease De Lombaerde, Stef
2019
72-73 C p. 40-48
artikel
498 Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy Verger, Elise

72-73 C p. 36-43
artikel
499 VMAT2 imaging agent, D6-[18F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization Zhao, Ruiyue
2019
72-73 C p. 26-35
artikel
500 VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation Tripathi, Sushil K.
2017
72-73 C p. 55-61
7 p.
artikel
501 What about α v β 3 integrins in molecular imaging in oncology? Debordeaux, Frederic

72-73 C p. 31-46
artikel
502 Whole-body biodistribution of the cannabinoid type 1 receptor ligand [18F]MK-9470 in the rat Buchholz, H.G.
2017
72-73 C p. 63-69
7 p.
artikel
503 William C. Eckelman: An anchor of stability with a quiet voice that nurtured a new field Katzenellenbogen, John A.

72-73 C p. 2-4
artikel
504 William C. Eckelman, an icon of radiopharmaceutical sciences Windhorst, A.D.

72-73 C p. 1
artikel
505 90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres Nezami, Nariman
2018
72-73 C p. 22-28
artikel
506 89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production Dias, Gemma M.
2018
72-73 C p. 1-7
artikel
507 [89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure Bansal, Aditya

72-73 C p. 23-30
artikel
                             507 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland